Specialists propose new framework for dialysis decisions in the elderly
By
Alicia Lasek
Mar 22, 2022
Older, frail patients with kidney failure may benefit from a new approach to dialysis discussions that supports a deferred decision, experts say.
Docs push for new COVID-19 funding as signs point to rebound in U.S. omicron cases
By
Alicia Lasek
Mar 17, 2022
The alternative is to risk leaving patients without access to needed vaccines, treatments and testing, the American College of Physicians has told Congress.
Fed’s booster OK too late? Nursing home loses 8 to coronavirus outbreak this fall
By
Alicia Lasek
Nov 17, 2021
A Connecticut nursing home has weathered a facility-wide COVID-19 outbreak that has sickened 89 residents and staff. Booster shots were not yet authorized when the first cases appeared, the operator reports.
Valid dementia verdict? Nursing home and hospital diagnoses now better aligned, study finds
By
Alicia Lasek
May 03, 2021
Medicare’s dementia claim measures appear to have become more sensitive in recent years, agreeing more closely with hospital-based measures overall and for certain populations than in the past, investigators...
FDA approves first-ever eye drop that corrects age-related vision loss
By
Alicia Lasek
Nov 02, 2021
The new drug, Vuity, adjusts pupil size and corrects near vision without affecting distance vision, drugmaker Allergan says.
LTC research hub to bring clinical trials to rural residents
By
Alicia Lasek
Sep 16, 2022
Nursing home operator Principle LTC and Care Access, a research organization, have launched a new research hub in Raleigh, NC, to provide rural residents access to clinical trials.
Brooks-LaSure: Medicare poised to re-evaluate coverage of new Alzheimer’s drugs
By
Alicia Lasek
Dec 12, 2022
In a Milken Institute summit session, the CMS administrator said that Medicare’s door is open to evaluating new data on emerging Alzheimer’s drug candidates.
SNF residents avoid repeat hospitalization with nurse-led heart failure program
By
Alicia Lasek
Sep 03, 2021
Sixty days after admission, patients in the disease management program had a lower composite rate of rehospitalization, ED visits or mortality when compared with their peers who had usual care. The program...
While FDA moves to halt mask reuse, N95 access remains spotty, report finds
By
Alicia Lasek
Apr 15, 2021
A new push to ensure that healthcare facilities stockpile single-use or reusable N95 respirators has arrived while some workers continue to lack access to the equipment and U.S. mask manufacturers can’t...
HHS halts Eli Lilly’s single-drug COVID antibody treatment in U.S.; dual-drug alternative remains in...
By
Alicia Lasek
Mar 26, 2021
U.S. distribution of an infusion treatment using bamlanivimab only has been halted due to virus variant concerns, but an alternative antibody cocktail from the drugmaker can still be ordered, according...